DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 50 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $190,000 | +53.2% | 33,000 | -15.4% | 0.11% | +43.6% |
| Q2 2017 | $124,000 | +169.6% | 39,000 | +188.9% | 0.08% | +169.0% |
| Q1 2017 | $46,000 | -63.5% | 13,500 | -69.1% | 0.03% | -63.3% |
| Q4 2016 | $126,000 | +34.0% | 43,719 | +173.2% | 0.08% | +31.7% |
| Q3 2016 | $94,000 | +56.7% | 16,000 | -20.0% | 0.06% | +53.8% |
| Q2 2016 | $60,000 | -85.4% | 20,000 | -20.0% | 0.04% | -84.5% |
| Q4 2014 | $412,000 | – | 25,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |